The invention relates to a crystalline form of [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)-piperidine-3,4,5-triol, processesfor the preparation thereof, pharmaceutical compositions containing such acrystalline form, and its use as a medicament, especiallyas glycolipid biosynthesis inhibitor